Motilal Oswal maintained a 'Buy' rating on Kaynes Technology, citing expected growth from scaling its core EMS business.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Motilal Oswal maintained a 'Buy' rating on Kaynes Technology, citing expected growth from scaling its core EMS business.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
EMS
pharmaceutical company
-
Motilal Oswal
Indian businessman